Roche Funds Large-Scale Bispecific Pair Screening
Roche agreed to pay Dualitas Therapeutics $36.5 million upfront for a research collaboration using Dualitas’ DualScreen platform to functionally test more than 300,000 bispecific combinations in immunology and inflammation. Research, development, and commercial milestones…
